Stock listing
Biofrontera Inc.
Selected listing: BFRI · NASDAQ · USD · US
Biofrontera Inc. (NASDAQ:BFRI), Health Technology. Latest release Sep 14, 2026: Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment…
- Ticker
- NASDAQ:BFRI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Biofrontera Inc.
Biofrontera Inc. is a public company traded under the ticker BFRI in the American market. Biofrontera focuses on developing and commercializing dermatological products.
Latest news from Biofrontera Inc.
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
September 14, 2026
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
August 13, 2026
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
August 5, 2026
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 21, 2026
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
May 13, 2026
Events
Research Biofrontera Inc.
Alternate listings
BFRI:BOATS
US · USD
Alternate listing for Biofrontera Inc.; the primary context on this page is BFRI:NASDAQ.
AI10:GETTEX
DE · EUR
Alternate listing for Biofrontera Inc.; the primary context on this page is BFRI:NASDAQ.
AI10:MUN
DE · EUR
Alternate listing for Biofrontera Inc.; the primary context on this page is BFRI:NASDAQ.
A3EFRZ:LSX
DE · EUR
Alternate listing for Biofrontera Inc.; the primary context on this page is BFRI:NASDAQ.